| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/13/2003 | CA2455329A1 Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv |
| 02/13/2003 | CA2455325A1 Method for the production of nucleic acids consisting of stochastically combined parts of source nucleic acids |
| 02/13/2003 | CA2455237A1 Compositions and methods for generating chimeric heteromultimers |
| 02/13/2003 | CA2455228A1 Antisense modulation of apolipoprotein b expression |
| 02/13/2003 | CA2455194A1 Vascular endothelial growth factor isoform having anti-angiogenic activity |
| 02/13/2003 | CA2455163A1 Method for producing arachidonic acid in transgenic organisms |
| 02/13/2003 | CA2455154A1 Receptor, the use thereof, and mouse antibodies |
| 02/13/2003 | CA2455147A1 Pregnancy-related enzyme activity |
| 02/13/2003 | CA2455100A1 Mediators of hedgehog signaling pathways,compositions and uses related thereto |
| 02/13/2003 | CA2455013A1 Systems for in vivo site-directed mutagenesis using oligonucleotides |
| 02/13/2003 | CA2454937A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | CA2454899A1 Engineering of living cells for the expression of holo-phycobiliprotein-based constructs |
| 02/13/2003 | CA2454850A1 Nucleic acids and encoded polypeptides associated with bipolar disorder |
| 02/13/2003 | CA2454700A1 A method to analyze nucleic acid(s) defining gene(s) exhibiting altered expression by schizophrenia |
| 02/13/2003 | CA2454696A1 Novel genetic products of ashbya gossypii, associated with the mechanisms of signal transduction and especially with the improvement of vitamin b2 production |
| 02/13/2003 | CA2454421A1 Use of long pentraxin ptx3 for treating female infertility |
| 02/13/2003 | CA2454372A1 Fatty acid desaturase gene obtained from pomegranate and method for the production of unsaturated fatty acids |
| 02/13/2003 | CA2454238A1 Method of detecting protease activity in a cell |
| 02/13/2003 | CA2454159A1 Methods for assessing the risk of obesity based on allelic variations in the 5'-flanking region of the insulin gene |
| 02/13/2003 | CA2454147A1 Inhibitor of dna methylation |
| 02/13/2003 | CA2453939A1 Identification of specific tumor antigens by means of the selection of cdna libraries with sera |
| 02/13/2003 | CA2453937A1 Antigenic polypeptides |
| 02/13/2003 | CA2453522A1 Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 02/13/2003 | CA2453372A1 Methylation resistant vectors |
| 02/13/2003 | CA2453178A1 Commercial use of arabidopsis for production of human and animal therapeutic and diagnostic proteins |
| 02/13/2003 | CA2451142A1 Carotenoid ketolase gene |
| 02/13/2003 | CA2439219A1 Plant stress regulated genes |
| 02/12/2003 | EP1283272A2 Methods and means for assessing HIV envelope inhibitor therapy |
| 02/12/2003 | EP1283268A2 Recombinant vascular endothelial cell growth factor D (VEGF-D) |
| 02/12/2003 | EP1283266A1 Transformant and process for producing polyester by using the same |
| 02/12/2003 | EP1283264A2 Interleukin-3 (IL-3) mutant polypeptides |
| 02/12/2003 | EP1283263A1 Modified cDNA for high expression levels of factor VIII and its derivatives |
| 02/12/2003 | EP1283262A1 Neurotrophic factor expression-inducing agent |
| 02/12/2003 | EP1283260A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof |
| 02/12/2003 | EP1283259A1 Chondroitin polymerase and DNA encoding the same |
| 02/12/2003 | EP1283258A1 Ornithine decarboxylase similar protein and nucleic acid molecules encoding it |
| 02/12/2003 | EP1283217A2 Antibodies against the IL-8 receptor, and their therapeutic uses |
| 02/12/2003 | EP1283215A2 Secreted polypeptide and nucleic acids encoding it |
| 02/12/2003 | EP1283214A1 Novel collectins |
| 02/12/2003 | EP1283212A1 Methods for identifying compounds that bind to a target |
| 02/12/2003 | EP1283057A1 Cell proliferation inhibitors |
| 02/12/2003 | EP1282816A2 Improved assay techniques using nematode worms |
| 02/12/2003 | EP1282728A2 Methods for clinical diagnosis |
| 02/12/2003 | EP1282727A1 Methods for identifying candidate polynucleotide molecules encoding a protease |
| 02/12/2003 | EP1282721A1 Prion-free transgenic ungulates |
| 02/12/2003 | EP1282717A1 Nucleotide sequences coding for signal transduction components involved in plant pathogen defence |
| 02/12/2003 | EP1282716A1 Method for producing recombinant proteins by gram-negative bacteria |
| 02/12/2003 | EP1282715A2 Method for microbial production of difructose anhydride iii, micro-organism used therefor and enzyme with inulase ii activity and dna sequences coding therefor |
| 02/12/2003 | EP1282714A2 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof |
| 02/12/2003 | EP1282713A2 Moss genes from physcomitrella patens encoding proteins involved in the synthesis of polyunsaturated fatty acids and lipids |
| 02/12/2003 | EP1282712A2 Synthetic gagpol genes and their uses |
| 02/12/2003 | EP1282711A2 COMPOUNDS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF i EHRLICHIA INFECTION /i |
| 02/12/2003 | EP1282710A2 Fish vaccine against piscirickettsia salmonis |
| 02/12/2003 | EP1282709A1 Method of modifying the content of cottonseed oil |
| 02/12/2003 | EP1282708A1 A method for generating hypermutable plants |
| 02/12/2003 | EP1282707A2 Regulation of human p2y-like g protein-coupled receptor |
| 02/12/2003 | EP1282706A2 Natrium-calcium exchanger protein |
| 02/12/2003 | EP1282705A2 Endothelial differentiation gene 6-like g protein coupled receptor |
| 02/12/2003 | EP1282704A2 Cng3b: a novel cyclic nucleotide-gated cation channel |
| 02/12/2003 | EP1282703A2 Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods |
| 02/12/2003 | EP1282702A2 Immunogenic polypeptides encoded by mage minigenes and uses thereof |
| 02/12/2003 | EP1282701A2 Novel neuronally expressed protein and use thereof |
| 02/12/2003 | EP1282700A1 Neuronal serine-threonine protein kinase |
| 02/12/2003 | EP1282699A2 Splice-region antisense composition and method |
| 02/12/2003 | EP1282698A2 Methods for the enzymatic assembly of polynucleotides and identification of polynucleotides having desired characteristics |
| 02/12/2003 | EP1282697A1 A construct capable of release in closed circular form from a larger nucleotide sequence permitting site specific expression and/or developmentally regulated expression of selected genetic sequences |
| 02/12/2003 | EP1282696A1 Ifi206, a novel interferon-induced polypeptide, and nucleic acids encoding the same |
| 02/12/2003 | EP1282693A1 Human coagulation factor vii variants |
| 02/12/2003 | EP1282692A2 Sentinel virus ii |
| 02/12/2003 | EP1282688A1 Ammonia-oxidizing bacteria |
| 02/12/2003 | EP1282685A2 Pluripotent cells comprising allogenic nucleus and mitochondria |
| 02/12/2003 | EP1282684A2 Chondroitin synthase gene and methods of making and using same |
| 02/12/2003 | EP1282646A2 Human monoclonal antibodies to dendritic cells |
| 02/12/2003 | EP1282644A1 Tm4sf receptor polynucleotides, polypeptides, and antibodies |
| 02/12/2003 | EP1282643A2 Anti-inflammatory compounds and uses thereof |
| 02/12/2003 | EP1282641A1 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector |
| 02/12/2003 | EP1282639A2 Polyamide nucleic acid derivatives, agents and methods for producing the same |
| 02/12/2003 | EP1282636A2 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 02/12/2003 | EP1282634A1 Atm mutations in breast cancer |
| 02/12/2003 | EP1282626A2 Polyketide derivatives |
| 02/12/2003 | EP1282469A2 System and method for manipulating magnetically responsive particles in fluid samples to collect dna or rna from a sample |
| 02/12/2003 | EP1282449A2 Treatment of human papillomavirus (hpv)-infected cells |
| 02/12/2003 | EP1282434A1 Method for cell adhesion and wound healing |
| 02/12/2003 | EP1282433A1 Transgenically produced decorin |
| 02/12/2003 | EP1282427A2 Immunostimulatory polynucleotide sequences for use in suppressing hepatitis virus infection |
| 02/12/2003 | EP1282403A1 Non-invasive gene targeting to the brain |
| 02/12/2003 | EP1226239A4 Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 02/12/2003 | EP1094833B1 Oxidized thymosin beta 4 |
| 02/12/2003 | EP1082460A4 A novel method of diagnosing, monitoring, and staging prostate cancer |
| 02/12/2003 | EP0938588B1 Signal amplification method |
| 02/12/2003 | EP0910658A4 Protein expression system |
| 02/12/2003 | EP0815261B1 Dna diagnostics based on mass spectrometry |
| 02/12/2003 | EP0728147B1 Receptor specific atrial natriuretic peptides |
| 02/12/2003 | EP0717749B1 Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics |
| 02/12/2003 | EP0694068B1 Genetic suppressor elements associated with sensitivity to chemotherapeutic drugs |
| 02/12/2003 | CN1396957A Method and kits for identifying elite event GAT-ZM1 in biological samples |
| 02/12/2003 | CN1396954A Support for fixing nucleotide and process for producing the same |
| 02/12/2003 | CN1396953A P450 monooxygenases of CYP79 family |
| 02/12/2003 | CN1396805A Transgenic coat producing milk containing human granulocyte-colony stimulating factor |
| 02/12/2003 | CN1396261A Human growth and differentiation factor 7 and its coding sequence preparing process and application |